82 related articles for article (PubMed ID: 12779056)
1. Improved synthesis and in vitro evaluation of quinuclidin-2-ene based ligands for the nicotinic acetylcholine receptor.
Seifert S; Gündisch D; Tilotta MC; Seitz G
Pharmazie; 2003 May; 58(5):353-4. PubMed ID: 12779056
[No Abstract] [Full Text] [Related]
2. 6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand.
Ramunno A; Dukat M; Lee M; Young R; El-Zahabi M; Damaj MI; Martin B; Glennon RA
Bioorg Med Chem Lett; 2005 Jul; 15(13):3237-40. PubMed ID: 15925512
[TBL] [Abstract][Full Text] [Related]
3. High affinity ligands for the alpha7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor.
Baker SR; Boot J; Brunavs M; Dobson D; Green R; Hayhurst L; Keenan M; Wallace L
Bioorg Med Chem Lett; 2005 Nov; 15(21):4727-30. PubMed ID: 16165358
[TBL] [Abstract][Full Text] [Related]
4. Quinuclidines as selective agonists for alpha-7 nicotinic acetylcholine receptors.
Leonik FM; Papke RL; Horenstein NA
Bioorg Med Chem Lett; 2007 Mar; 17(6):1520-2. PubMed ID: 17276680
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological characterization of [(125)I]iodomethyllycaconitine ([(125)I]iodo-MLA). A new ligand for the alpha(7) nicotinic acetylcholine receptor.
Navarro HA; Zhong D; Abraham P; Xu H; Carroll FI
J Med Chem; 2000 Jan; 43(2):142-5. PubMed ID: 10649969
[No Abstract] [Full Text] [Related]
6. Synthesis and nicotinic binding studies on enantiopure pinnamine variants with an 8-azabicyclo[3.2.1]octane moiety.
Schwarz S; Kämpchen T; Tilotta MC; Gündisch D; Seitz G
Pharmazie; 2003 May; 58(5):295-9. PubMed ID: 12779043
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
Faghih R; Gopalakrishnan M; Briggs CA
J Med Chem; 2008 Feb; 51(4):701-12. PubMed ID: 18198823
[No Abstract] [Full Text] [Related]
9. 2. Medicinal chemistry of alpha4beta2 nicotinic cholinergic receptor ligands.
Glennon RA
Prog Med Chem; 2004; 42():55-123. PubMed ID: 15003719
[No Abstract] [Full Text] [Related]
10. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP
Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544
[TBL] [Abstract][Full Text] [Related]
11. Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis.
Nielsen SF; Nielsen EO; Olsen GM; Liljefors T; Peters D
J Med Chem; 2000 Jun; 43(11):2217-26. PubMed ID: 10841800
[TBL] [Abstract][Full Text] [Related]
12. Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies.
Zlotos DP; Gündisch D; Ferraro S; Tilotta MC; Stiefl N; Baumann K
Bioorg Med Chem; 2004 Dec; 12(23):6277-85. PubMed ID: 15519170
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agents.
Muth M; Sennwitz M; Mohr K; Holzgrabe U
J Med Chem; 2005 Mar; 48(6):2212-7. PubMed ID: 15771463
[TBL] [Abstract][Full Text] [Related]
15. Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptors.
Barker D; Lin DH; Carland JE; Chu CP; Chebib M; Brimble MA; Savage GP; McLeod MD
Bioorg Med Chem; 2005 Jul; 13(14):4565-75. PubMed ID: 15922601
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.
Lainé DI; McCleland B; Thomas S; Neipp C; Underwood B; Dufour J; Widdowson KL; Palovich MR; Blaney FE; Foley JJ; Webb EF; Luttmann MA; Burman M; Belmonte K; Salmon M
J Med Chem; 2009 Apr; 52(8):2493-505. PubMed ID: 19317446
[TBL] [Abstract][Full Text] [Related]
17. New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modeling.
Audouze K; Nielsen EØ; Olsen GM; Ahring P; Jørgensen TD; Peters D; Liljefors T; Balle T
J Med Chem; 2006 Jun; 49(11):3159-71. PubMed ID: 16722635
[TBL] [Abstract][Full Text] [Related]
18. Screening structural-functional relationships of neuropharmacologically active organic compounds at the nicotinic acetylcholine receptor.
Barrantes GE; Ortells MO; Barrantes FJ
Neuropharmacology; 1997 Mar; 36(3):269-79. PubMed ID: 9175605
[TBL] [Abstract][Full Text] [Related]
19. Potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives.
Patel AB; Malpass JR
J Med Chem; 2008 Nov; 51(21):7005-9. PubMed ID: 18841955
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
Carroll FI; Hu X; Navarro HA; Deschamps J; Abdrakhmanova GR; Damaj MI; Martin BR
J Med Chem; 2006 Jun; 49(11):3244-50. PubMed ID: 16722642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
